One can speculate that potentially CDK4/6 is mutated in these cell lines and does not allow PD 0332991 binding and kinase inhibition, as is the case in resistance to BCR-ABL inhibitors in chronic myelogenous leukemia [35]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.